BRAF and melanoma: Hence, our findings support that BRAF mutational status alone does not have prognostic value in primary melanomas in order to predict the risk of developing metastasis or death and, therefore, it is necessary to include other prognostic variables such as the expression of miR-125b, miR-200c and miR-205.